{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:49:34Z","timestamp":1790488174681,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001677","name":"INSERM","doi-asserted-by":"crossref","award":["1119"],"award-info":[{"award-number":["1119"]}],"id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003768","name":"Universit\u00e9 de Strasbourg","doi-asserted-by":"publisher","award":["UMR_S 1119"],"award-info":[{"award-number":["UMR_S 1119"]}],"id":[{"id":"10.13039\/501100003768","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Education, Universities and Research","award":["2017MT3993"],"award-info":[{"award-number":["2017MT3993"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12035-022-02737-2","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T17:02:41Z","timestamp":1641920561000},"page":"1744-1765","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis"],"prefix":"10.1007","volume":"59","author":[{"given":"Chiara","family":"Tremolanti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cavallini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Da Pozzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Germelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Taliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Patte-Mensah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayiko\u00e9-Guy","family":"Mensah-Nyagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"2737_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683\u2013747. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115707","journal-title":"Annu Rev Immunol"},{"issue":"9648","key":"2737_CR2","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372(9648):1502\u20131517. https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7","journal-title":"Lancet"},{"issue":"1","key":"2737_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","volume":"4","author":"M Filippi","year":"2018","unstructured":"Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, Rocca MA (2018) Multiple sclerosis Nat Rev Dis Primers 4(1):43. https:\/\/doi.org\/10.1038\/s41572-018-0041-4","journal-title":"Multiple sclerosis Nat Rev Dis Primers"},{"issue":"5","key":"2737_CR4","doi-asserted-by":"publisher","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","volume":"9","author":"R Milo","year":"2010","unstructured":"Milo R, Kahana E (2010) Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 9(5):A387\u2013A394. https:\/\/doi.org\/10.1016\/j.autrev.2009.11.010","journal-title":"Autoimmun Rev"},{"issue":"9","key":"2737_CR5","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.3174\/ajnr.A5148","volume":"38","author":"C McNamara","year":"2017","unstructured":"McNamara C, Sugrue G, Murray B, MacMahon PJ (2017) Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression. AJNR Am J Neuroradiol 38(9):1672\u20131680. https:\/\/doi.org\/10.3174\/ajnr.A5148","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"2737_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41582-018-0127-3","volume":"15","author":"MA Rocca","year":"2019","unstructured":"Rocca MA, Filippi M (2019) Targeting progression in multiple sclerosis - an update. Nat Rev Neurol 15(2):62\u201364. https:\/\/doi.org\/10.1038\/s41582-018-0127-3","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"2737_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1474-4422(14)70231-5","volume":"14","author":"A Feinstein","year":"2015","unstructured":"Feinstein A, Freeman J, Lo AC (2015) Treatment of progressive multiple sclerosis: what works, what does not, and what is needed. Lancet Neurol 14(2):194\u2013207. https:\/\/doi.org\/10.1016\/S1474-4422(14)70231-5","journal-title":"Lancet Neurol"},{"issue":"12","key":"2737_CR8","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41573-019-0035-2","volume":"18","author":"S Faissner","year":"2019","unstructured":"Faissner S, Plemel JR, Gold R, Yong VW (2019) Progressive multiple sclerosis: from pathophysiology to therapeutic strategies. Nat Rev Drug Discov 18(12):905\u2013922. https:\/\/doi.org\/10.1038\/s41573-019-0035-2","journal-title":"Nat Rev Drug Discov"},{"issue":"7","key":"2737_CR9","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/eji.1830250723","volume":"25","author":"I Mendel","year":"1995","unstructured":"Mendel I, Kerlero de Rosbo N, Ben-Nun A (1995) A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol 25(7):1951\u20131959. https:\/\/doi.org\/10.1002\/eji.1830250723","journal-title":"Eur J Immunol"},{"issue":"10","key":"2737_CR10","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/brain\/awq237","volume":"133","author":"DK Crawford","year":"2010","unstructured":"Crawford DK, Mangiardi M, Song B, Patel R, Du S, Sofroniew MV, Voskuhl RR, Tiwari-Woodruff SK (2010) Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Brain 133(10):2999\u20133016. https:\/\/doi.org\/10.1093\/brain\/awq237","journal-title":"Brain"},{"issue":"3","key":"2737_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1750-3639.2010.00444.x","volume":"21","author":"M Mangiardi","year":"2011","unstructured":"Mangiardi M, Crawford DK, Xia X, Du S, Simon-Freeman R, Voskuhl RR, Tiwari-Woodruff SK (2011) An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol 21(3):263\u2013278. https:\/\/doi.org\/10.1111\/j.1750-3639.2010.00444.x","journal-title":"Brain Pathol"},{"issue":"4","key":"2737_CR12","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/nprot.2006.285","volume":"1","author":"IM Stromnes","year":"2006","unstructured":"Stromnes IM, Goverman JM (2006) Active induction of experimental allergic encephalomyelitis. Nat Protoc 1(4):1810\u20131819. https:\/\/doi.org\/10.1038\/nprot.2006.285","journal-title":"Nat Protoc"},{"key":"2737_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1749-6632.2002.tb02944.x","volume":"958","author":"SM Tompkins","year":"2002","unstructured":"Tompkins SM, Fuller KG, Miller SD (2002) Theiler\u2019s virus-mediated autoimmunity: local presentation of CNS antigens and epitope spreading. Ann N Y Acad Sci 958:26\u201338","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2737_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.expneurol.2009.10.009","volume":"225","author":"H Lassmann","year":"2010","unstructured":"Lassmann H (2010) Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models. Exp Neurol 225(1):2\u20138. https:\/\/doi.org\/10.1016\/j.expneurol.2009.10.009","journal-title":"Exp Neurol"},{"issue":"8","key":"2737_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff RM (2012) Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci 15(8):1074\u20131077. https:\/\/doi.org\/10.1038\/nn.3168","journal-title":"Nat Neurosci"},{"key":"2737_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jneumeth.2017.04.003","volume":"284","author":"JPC Hasselmann","year":"2017","unstructured":"Hasselmann JPC, Karim H, Khalaj AJ, Ghosh S, Tiwari-Woodruff SK (2017) Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL\/6 mice for the longitudinal study of pathology and repair. J Neurosci Methods 284:71\u201384. https:\/\/doi.org\/10.1016\/j.jneumeth.2017.04.003","journal-title":"J Neurosci Methods"},{"issue":"6\u20137","key":"2737_CR17","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/s0035-3787(07)90474-9","volume":"163","author":"H Lassmann","year":"2007","unstructured":"Lassmann H (2007) Experimental models of multiple sclerosis. Rev Neurol (Paris) 163(6\u20137):651\u2013655. https:\/\/doi.org\/10.1016\/s0035-3787(07)90474-9","journal-title":"Rev Neurol (Paris)"},{"key":"2737_CR18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/B978-0-444-52001-2.00008-X","volume":"122","author":"AP Robinson","year":"2014","unstructured":"Robinson AP, Harp CT, Noronha A, Miller SD (2014) The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol 122:173\u2013189. https:\/\/doi.org\/10.1016\/B978-0-444-52001-2.00008-X","journal-title":"Handb Clin Neurol"},{"key":"2737_CR19","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1016\/j.bbadis.2017.09.007","volume":"12","author":"G Leva","year":"1863","unstructured":"Leva G, Klein C, Benyounes J, Halle F, Bihel F, Collongues N, De Seze J (1863) Mensah-Nyagan AG and Patte-Mensah C (2017) The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL\/J mouse model of multiple sclerosis. Biochim Biophys Acta Mol Basis Dis 12:3016\u20133027. https:\/\/doi.org\/10.1016\/j.bbadis.2017.09.007","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"6","key":"2737_CR20","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/emmm.201202124","volume":"5","author":"DJ Daugherty","year":"2013","unstructured":"Daugherty DJ, Selvaraj V, Chechneva OV, Liu XB, Pleasure DE, Deng W (2013) A TSPO ligand is protective in a mouse model of multiple sclerosis. EMBO Mol Med 5(6):891\u2013903. https:\/\/doi.org\/10.1002\/emmm.201202124","journal-title":"EMBO Mol Med"},{"key":"2737_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12974-015-0422-5","volume":"12","author":"R Scholz","year":"2015","unstructured":"Scholz R, Caramoy A, Bhuckory MB, Rashid K, Chen M, Xu H, Grimm C, Langmann T (2015) Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration. J Neuroinflammation 12:201. https:\/\/doi.org\/10.1186\/s12974-015-0422-5","journal-title":"J Neuroinflammation"},{"key":"2737_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuropharm.2016.03.053","volume":"108","author":"B Ravikumar","year":"2016","unstructured":"Ravikumar B, Crawford D, Dellovade T, Savinainen A, Graham D, Liere P, Oudinet JP, Webb M, Hering H (2016) Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis. Neuropharmacology 108:229\u2013237. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.03.053","journal-title":"Neuropharmacology"},{"issue":"2","key":"2737_CR23","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/cells9020512","volume":"9","author":"C Betlazar","year":"2020","unstructured":"Betlazar C, Middleton RJ, Banati R, Liu GJ (2020) The Translocator Protein (TSPO) in Mitochondrial Bioenergetics and Immune Processes. Cells 9(2):512. https:\/\/doi.org\/10.3390\/cells9020512","journal-title":"Cells"},{"issue":"4\u20136","key":"2737_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0960-0760(94)90284-4","volume":"49","author":"E Costa","year":"1994","unstructured":"Costa E, Auta J, Guidotti A, Korneyev A, Romeo E (1994) The pharmacology of neurosteroidogenesis. J Steroid Biochem Mol Biol 49(4\u20136):385\u2013389. https:\/\/doi.org\/10.1016\/0960-0760(94)90284-4","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"1","key":"2737_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1365-2826.2004.01226.x","volume":"51","author":"AG Mensah-Nyagan","year":"1999","unstructured":"Mensah-Nyagan AG, Do-Rego JL, Beaujean D, Luu-The V, Pelletier G, Vaudry H (1999) Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol Rev 51(1):63\u201381. https:\/\/doi.org\/10.1111\/j.1365-2826.2004.01226.x","journal-title":"Pharmacol Rev"},{"issue":"4","key":"2737_CR26","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1046\/j.1471-4159.2003.01881.x","volume":"86","author":"AM Ghoumari","year":"2003","unstructured":"Ghoumari AM, Ibanez C, El-Etr M, Leclerc P, Eychenne B, O\u2019Malley BW, Baulieu EE, Schumacher M (2003) Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 86(4):848\u2013859. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01881.x","journal-title":"J Neurochem"},{"key":"2737_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2013.09.005","volume":"113","author":"RC Melcangi","year":"2014","unstructured":"Melcangi RC, Panzica GC (2014) Allopregnanolone: state of the art. Prog Neurobiol 113:1\u20135. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.09.005","journal-title":"Prog Neurobiol"},{"issue":"134","key":"2737_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2014.00134","volume":"8","author":"F Noorbakhsh","year":"2014","unstructured":"Noorbakhsh F, Baker GB, Power C (2014) Allopregnanolone and neuroinflammation: a focus on multiple sclerosis. Front Cell Neurosci 8(134):1\u20136. https:\/\/doi.org\/10.3389\/fncel.2014.00134","journal-title":"Front Cell Neurosci"},{"key":"2737_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-021-01118-y","author":"AF De Nicola","year":"2021","unstructured":"De Nicola AF, Meyer M, Garay L, Kruse MS, Schumacher M, Guennoun R, Gonzalez Deniselle MC (2021) Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-021-01118-y","journal-title":"Cell Mol Neurobiol"},{"issue":"3","key":"2737_CR30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3390\/cells10030698","volume":"10","author":"V Jolivel","year":"2021","unstructured":"Jolivel V, Brun S, Biname F, Benyounes J, Taleb O, Bagnard D, De Seze J, Patte-Mensah C, Mensah-Nyagan AG (2021) Microglial Cell Morphology and Phagocytic Activity Are Critically Regulated by the Neurosteroid Allopregnanolone: A Possible Role in Neuroprotection. Cells 10(3):698. https:\/\/doi.org\/10.3390\/cells10030698","journal-title":"Cells"},{"issue":"18","key":"2737_CR31","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.3390\/ijms20184467","volume":"20","author":"ED Da Pozzo","year":"2019","unstructured":"Da Pozzo ED, Tremolanti C, Costa B, Giacomelli C, Milenkovic VM, Bader S, Wetzel CH, Rupprecht R, Taliani S, Settimo FD, Martini C (2019) Microglial Pro-Inflammatory and Anti-Inflammatory Phenotypes Are Modulated by Translocator Protein Activation. Int J Mol Sci 20(18):4467. https:\/\/doi.org\/10.3390\/ijms20184467","journal-title":"Int J Mol Sci"},{"issue":"15","key":"2737_CR32","doi-asserted-by":"publisher","first-page":"6081","DOI":"10.1021\/acs.jmedchem.5b00689","volume":"58","author":"E Barresi","year":"2015","unstructured":"Barresi E, Bruno A, Taliani S, Cosconati S, Da Pozzo E, Salerno S, Simorini F, Daniele S, Giacomelli C, Marini AM, La Motta C, Marinelli L, Cosimelli B, Novellino E, Greco G, Da Settimo F, Martini C (2015) Deepening the Topology of the Translocator Protein Binding Site by Novel N, N-Dialkyl-2-arylindol-3-ylglyoxylamides. J Med Chem 58(15):6081\u20136092. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00689","journal-title":"J Med Chem"},{"issue":"13","key":"2737_CR33","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.3390\/ijms20133359","volume":"20","author":"VM Milenkovic","year":"2019","unstructured":"Milenkovic VM, Slim D, Bader S, Koch V, Heinl ES, Alvarez-Carbonell D, Nothdurfter C, Rupprecht R, Wetzel CH (2019) CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells. Int J Mol Sci 20(13):3359. https:\/\/doi.org\/10.3390\/ijms20133359","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2737_CR34","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ijms17071028","volume":"17","author":"E Da Pozzo","year":"2016","unstructured":"Da Pozzo E, Giacomelli C, Costa B, Cavallini C, Taliani S, Barresi E, Da Settimo F, Martini C (2016) TSPO PIGA Ligands Promote Neurosteroidogenesis and Human Astrocyte Well-Being. Int J Mol Sci 17(7):1028. https:\/\/doi.org\/10.3390\/ijms17071028","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2737_CR35","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3390\/ijms22063115","volume":"22","author":"L Germelli","year":"2021","unstructured":"Germelli L, Da Pozzo E, Giacomelli C, Tremolanti C, Marchetti L, Wetzel CH, Barresi E, Taliani S, Da Settimo F, Martini C, Costa B (2021) De novo Neurosteroidogenesis in Human Microglia: Involvement of the 18 kDa Translocator Protein. Int J Mol Sci 22(6):3115. https:\/\/doi.org\/10.3390\/ijms22063115","journal-title":"Int J Mol Sci"},{"key":"2737_CR36","doi-asserted-by":"publisher","first-page":"18164","DOI":"10.1038\/srep18164","volume":"6","author":"B Costa","year":"2016","unstructured":"Costa B, Da Pozzo E, Giacomelli C, Barresi E, Taliani S, Da Settimo F, Martini C (2016) TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy. Sci Rep 6:18164. https:\/\/doi.org\/10.1038\/srep18164","journal-title":"Sci Rep"},{"issue":"16","key":"2737_CR37","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1002\/cmdc.201700220","volume":"12","author":"B Costa","year":"2017","unstructured":"Costa B, Taliani S, Da Pozzo E, Barresi E, Robello M, Cavallini C, Cosconati S, Da Settimo F, Novellino E, Martini C (2017) Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N, N-Dialkyl-2-arylindol-3-ylglyoxylamides. ChemMedChem 12(16):1275\u20131278. https:\/\/doi.org\/10.1002\/cmdc.201700220","journal-title":"ChemMedChem"},{"issue":"18","key":"2737_CR38","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1021\/jm8003224","volume":"51","author":"F Da Settimo","year":"2008","unstructured":"Da Settimo F, Simorini F, Taliani S, La Motta C, Marini AM, Salerno S, Bellandi M, Novellino E, Greco G, Cosimelli B, Da Pozzo E, Costa B, Simola N, Morelli M, Martini C (2008) Anxiolytic-like effects of N, N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis. J Med Chem 51(18):5798\u20135806. https:\/\/doi.org\/10.1021\/jm8003224","journal-title":"J Med Chem"},{"issue":"1","key":"2737_CR39","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s12859-017-1934-z","volume":"18","author":"CT Rueden","year":"2017","unstructured":"Rueden CT, Schindelin J, Hiner MC, DeZonia BE, Walter AE, Arena ET, Eliceiri KW (2017) Image J2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18(1):529. https:\/\/doi.org\/10.1186\/s12859-017-1934-z","journal-title":"BMC Bioinformatics"},{"issue":"6","key":"2737_CR40","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1365-2826.2012.02284.x","volume":"24","author":"S Giatti","year":"2012","unstructured":"Giatti S, Caruso D, Boraso M, Abbiati F, Ballarini E, Calabrese D, Pesaresi M, Rigolio R, Santos-Galindo M, Viviani B, Cavaletti G, Garcia-Segura LM, Melcangi RC (2012) Neuroprotective effects of progesterone in chronic experimental autoimmune encephalomyelitis. J Neuroendocrinol 24(6):851\u2013861. https:\/\/doi.org\/10.1111\/j.1365-2826.2012.02284.x","journal-title":"J Neuroendocrinol"},{"issue":"3","key":"2737_CR41","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s13659-019-0204-3","volume":"9","author":"Q Liu","year":"2019","unstructured":"Liu Q, Chi Q, Fan RT, Tian HD, Wang X (2019) Quantitative-Profiling Method of Serum Steroid Hormones by Hydroxylamine-Derivatization HPLC-MS. Nat Prod Bioprospect 9(3):201\u2013208. https:\/\/doi.org\/10.1007\/s13659-019-0204-3","journal-title":"Nat Prod Bioprospect"},{"key":"2737_CR42","doi-asserted-by":"publisher","unstructured":"Kriszta G, Nemes B, Sandor Z, Acs P, Komoly S, Berente Z, Bolcskei K and Pinter E (2019) Investigation of Cuprizone-Induced Demyelination in mGFAP-Driven Conditional Transient Receptor Potential Ankyrin 1 (TRPA1) Receptor Knockout Mice. Cells 9(1):https:\/\/doi.org\/10.3390\/cells9010081.","DOI":"10.3390\/cells9010081"},{"issue":"12","key":"2737_CR43","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1002\/glia.23051","volume":"64","author":"E Saghy","year":"2016","unstructured":"Saghy E, Sipos E, Acs P, Bolcskei K, Pohoczky K, Kemeny A, Sandor Z, Szoke E, Setalo G Jr, Komoly S, Pinter E (2016) TRPA1 deficiency is protective in cuprizone-induced demyelination-A new target against oligodendrocyte apoptosis. Glia 64(12):2166\u20132180. https:\/\/doi.org\/10.1002\/glia.23051","journal-title":"Glia"},{"key":"2737_CR44","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1146\/annurev.iy.10.040192.001101","volume":"10","author":"R Martin","year":"1992","unstructured":"Martin R, McFarland HF, McFarlin DE (1992) Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153\u2013187. https:\/\/doi.org\/10.1146\/annurev.iy.10.040192.001101","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"2737_CR45","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.celrep.2016.06.008","volume":"16","author":"MT Weil","year":"2016","unstructured":"Weil MT, Mobius W, Winkler A, Ruhwedel T, Wrzos C, Romanelli E, Bennett JL, Enz L, Goebels N, Nave KA, Kerschensteiner M, Schaeren-Wiemers N, Stadelmann C, Simons M (2016) Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases. Cell Rep 16(2):314\u2013322. https:\/\/doi.org\/10.1016\/j.celrep.2016.06.008","journal-title":"Cell Rep"},{"issue":"Pt 5","key":"2737_CR46","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1093\/brain\/awp106","volume":"132","author":"EC Tallantyre","year":"2009","unstructured":"Tallantyre EC, Bo L, Al-Rawashdeh O, Owens T, Polman CH, Lowe J, Evangelou N (2009) Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease. Brain 132(Pt 5):1190\u20131199. https:\/\/doi.org\/10.1093\/brain\/awp106","journal-title":"Brain"},{"issue":"8","key":"2737_CR47","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3969\/j.issn.1673-5374.2012.08.010","volume":"7","author":"H Wang","year":"2012","unstructured":"Wang H, Wu M, Zhan C, Ma E, Yang M, Yang X, Li Y (2012) Neurofilament proteins in axonal regeneration and neurodegenerative diseases. Neural Regen Res 7(8):620\u2013626. https:\/\/doi.org\/10.3969\/j.issn.1673-5374.2012.08.010","journal-title":"Neural Regen Res"},{"key":"2737_CR48","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3389\/fneur.2017.00312","volume":"8","author":"A Wilkins","year":"2017","unstructured":"Wilkins A (2017) Cerebellar Dysfunction in Multiple Sclerosis. Front Neurol 8:312. https:\/\/doi.org\/10.3389\/fneur.2017.00312","journal-title":"Front Neurol"},{"issue":"5","key":"2737_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2990.1982.tb00308.x","volume":"8","author":"H Nyland","year":"1982","unstructured":"Nyland H, Mork S, Matre R (1982) In-situ characterization of mononuclear cell infiltrates in lesions of multiple sclerosis. Neuropathol Appl Neurobiol 8(5):403\u2013411. https:\/\/doi.org\/10.1111\/j.1365-2990.1982.tb00308.x","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"4","key":"2737_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrn784","volume":"3","author":"B Hemmer","year":"2002","unstructured":"Hemmer B, Archelos JJ, Hartung HP (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3(4):291\u2013301. https:\/\/doi.org\/10.1038\/nrn784","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"2737_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5493\/wjem.v4.i3.27","volume":"4","author":"RA Hoglund","year":"2014","unstructured":"Hoglund RA, Maghazachi AA (2014) Multiple sclerosis and the role of immune cells. World J Exp Med 4(3):27\u201337. https:\/\/doi.org\/10.5493\/wjem.v4.i3.27","journal-title":"World J Exp Med"},{"issue":"7","key":"2737_CR52","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","volume":"161","author":"E Bettelli","year":"1998","unstructured":"Bettelli E, Das MP, Howard ED, Weiner HL, Sobel RA, Kuchroo VK (1998) IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161(7):3299\u20133306","journal-title":"J Immunol"},{"issue":"Pt A","key":"2737_CR53","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.neuropharm.2014.10.020","volume":"96","author":"AJ Kwilasz","year":"2015","unstructured":"Kwilasz AJ, Grace PM, Serbedzija P, Maier SF, Watkins LR (2015) The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology 96(Pt A):55\u201369. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.10.020","journal-title":"Neuropharmacology"},{"issue":"4","key":"2737_CR54","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/1352458518763094","volume":"24","author":"K Gobel","year":"2018","unstructured":"Gobel K, Ruck T, Meuth SG (2018) Cytokine signaling in multiple sclerosis: Lost in translation. Mult Scler 24(4):432\u2013439. https:\/\/doi.org\/10.1177\/1352458518763094","journal-title":"Mult Scler"},{"issue":"4","key":"2737_CR55","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","volume":"164","author":"CS Constantinescu","year":"2011","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B (2011) Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). Br J Pharmacol 164(4):1079\u20131106. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01302.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"2737_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/bpa.12454","volume":"27","author":"M Kipp","year":"2017","unstructured":"Kipp M, Nyamoya S, Hochstrasser T, Amor S (2017) Multiple sclerosis animal models: a clinical and histopathological perspective. Brain Pathol 27(2):123\u2013137. https:\/\/doi.org\/10.1111\/bpa.12454","journal-title":"Brain Pathol"},{"issue":"3\u20134","key":"2737_CR57","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/neu.2006.23.537","volume":"23","author":"FP Hamers","year":"2006","unstructured":"Hamers FP, Koopmans GC, Joosten EA (2006) CatWalk-assisted gait analysis in the assessment of spinal cord injury. J Neurotrauma 23(3\u20134):537\u2013548. https:\/\/doi.org\/10.1089\/neu.2006.23.537","journal-title":"J Neurotrauma"},{"issue":"1","key":"2737_CR58","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13104-018-3374-x","volume":"11","author":"ST Crowley","year":"2018","unstructured":"Crowley ST, Kataoka K, Itaka K (2018) Combined CatWalk Index: an improved method to measure mouse motor function using the automated gait analysis system. BMC Res Notes 11(1):263. https:\/\/doi.org\/10.1186\/s13104-018-3374-x","journal-title":"BMC Res Notes"},{"issue":"10","key":"2737_CR59","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1073\/pnas.84.10.3472","volume":"84","author":"PN Hoffman","year":"1987","unstructured":"Hoffman PN, Cleveland DW, Griffin JW, Landes PW, Cowan NJ, Price DL (1987) Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A 84(10):3472\u20133476. https:\/\/doi.org\/10.1073\/pnas.84.10.3472","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2737_CR60","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1089\/neu.2005.22.1066","volume":"22","author":"CR Marmarou","year":"2005","unstructured":"Marmarou CR, Walker SA, Davis CL, Povlishock JT (2005) Quantitative analysis of the relationship between intra- axonal neurofilament compaction and impaired axonal transport following diffuse traumatic brain injury. J Neurotrauma 22(10):1066\u20131080. https:\/\/doi.org\/10.1089\/neu.2005.22.1066","journal-title":"J Neurotrauma"},{"issue":"2","key":"2737_CR61","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1136\/jnnp.2004.043315","volume":"76","author":"A Petzold","year":"2005","unstructured":"Petzold A, Eikelenboom MJ, Keir G, Grant D, Lazeron RH, Polman CH, Uitdehaag BM, Thompson EJ, Giovannoni G (2005) Axonal damage accumulates in the progressive phase of multiple sclerosis: three year follow up study. J Neurol Neurosurg Psychiatry 76(2):206\u2013211. https:\/\/doi.org\/10.1136\/jnnp.2004.043315","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"2737_CR62","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/biomedicines7010014","volume":"7","author":"J Correale","year":"2019","unstructured":"Correale J, Marrodan M, Ysrraelit MC (2019) Mechanisms of Neurodegeneration and Axonal Dysfunction in Progressive Multiple Sclerosis. Biomedicines 7(1):14. https:\/\/doi.org\/10.3390\/biomedicines7010014","journal-title":"Biomedicines"},{"issue":"9","key":"2737_CR63","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nri3871","volume":"15","author":"CA Dendrou","year":"2015","unstructured":"Dendrou CA, Fugger L, Friese MA (2015) Immunopathology of multiple sclerosis. Nat Rev Immunol 15(9):545\u2013558. https:\/\/doi.org\/10.1038\/nri3871","journal-title":"Nat Rev Immunol"},{"key":"2737_CR64","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.bbadis.2015.10.018","volume":"3","author":"MA Lopes Pinheiro","year":"1862","unstructured":"Lopes Pinheiro MA, Kooij G, Mizee MR, Kamermans A, Enzmann G, Lyck R, Schwaninger M (1862) Engelhardt B and de Vries HE (2016) Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke. Biochim Biophys Acta 3:461\u2013471. https:\/\/doi.org\/10.1016\/j.bbadis.2015.10.018","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"2737_CR65","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/cells8111314","volume":"8","author":"MK Sen","year":"2019","unstructured":"Sen MK, Almuslehi MSM, Gyengesi E, Myers SJ, Shortland PJ, Mahns DA, Coorssen JR (2019) Suppression of the Peripheral Immune System Limits the Central Immune Response Following Cuprizone-Feeding: Relevance to Modelling Multiple Sclerosis. Cells 8(11):1314. https:\/\/doi.org\/10.3390\/cells8111314","journal-title":"Cells"},{"key":"2737_CR66","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.3389\/fimmu.2020.01884","volume":"11","author":"Z Ran","year":"2020","unstructured":"Ran Z, Yue-Bei L, Qiu-Ming Z, Huan Y (2020) Regulatory B Cells and Its Role in Central Nervous System Inflammatory Demyelinating Diseases. Front Immunol 11:1884. https:\/\/doi.org\/10.3389\/fimmu.2020.01884","journal-title":"Front Immunol"},{"issue":"4\u20135","key":"2737_CR67","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.neuint.2007.09.010","volume":"52","author":"RC Melcangi","year":"2008","unstructured":"Melcangi RC, Mensah-Nyagan AG (2008) Neurosteroids: measurement and pathophysiologic relevance. Neurochem Int 52(4\u20135):503\u2013505. https:\/\/doi.org\/10.1016\/j.neuint.2007.09.010","journal-title":"Neurochem Int"},{"issue":"4","key":"2737_CR68","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.psyneuen.2010.07.021","volume":"36","author":"B Costa","year":"2011","unstructured":"Costa B, Da Pozzo E, Chelli B, Simola N, Morelli M, Luisi M, Maccheroni M, Taliani S, Simorini F, Da Settimo F, Martini C (2011) Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity. Psychoneuroendocrinology 36(4):463\u2013472. https:\/\/doi.org\/10.1016\/j.psyneuen.2010.07.021","journal-title":"Psychoneuroendocrinology"},{"key":"2737_CR69","doi-asserted-by":"publisher","unstructured":"Mancino DN, Leicaj ML, Lima A, Roig P, Guennoun R, Schumacher M, De Nicola AF and Garay LI (2021) Developmental expression of genes involved in progesterone synthesis, metabolism and action during the post-natal cerebellar myelination. J Steroid Biochem Mol Biol 207(105820):https:\/\/doi.org\/10.1016\/j.jsbmb.2021.105820.","DOI":"10.1016\/j.jsbmb.2021.105820"},{"issue":"1","key":"2737_CR70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2826.2011.02215.x","volume":"24","author":"C Girard","year":"2012","unstructured":"Girard C, Liu S, Adams D, Lacroix C, Sineus M, Boucher C, Papadopoulos V, Rupprecht R, Schumacher M, Groyer G (2012) Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa. J Neuroendocrinol 24(1):71\u201381. https:\/\/doi.org\/10.1111\/j.1365-2826.2011.02215.x","journal-title":"J Neuroendocrinol"},{"key":"2737_CR71","unstructured":"Pawlikowski M, Immunomodulating effects of peripherally acting benzodiazepines, In: Giesen-Crouse E, Editor. Peripheral benzodiazepine receptors. Academic Press; 1993. London. p. 125\u201335."},{"key":"2737_CR72","doi-asserted-by":"publisher","unstructured":"Qi X, Xu J, Wang F and Xiao J (2012) Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases. Oxid Med Cell Longev 2012(162934):https:\/\/doi.org\/10.1155\/2012\/162934.","DOI":"10.1155\/2012\/162934"},{"issue":"4","key":"2737_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2174\/1566524011207040369","volume":"12","author":"J Fan","year":"2012","unstructured":"Fan J, Lindemann P, Feuilloley MG, Papadopoulos V (2012) Structural and functional evolution of the translocator protein (18 kDa). Curr Mol Med 12(4):369\u2013386. https:\/\/doi.org\/10.2174\/1566524011207040369","journal-title":"Curr Mol Med"},{"key":"2737_CR74","doi-asserted-by":"publisher","unstructured":"Costa B, Da Pozzo E and Martini C (2020) 18-kDa translocator protein association complexes in the brain: From structure to function. Biochem Pharmacol 177(114015):https:\/\/doi.org\/10.1016\/j.bcp.2020.114015.","DOI":"10.1016\/j.bcp.2020.114015"},{"issue":"6","key":"2737_CR75","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.3390\/ijms19061694","volume":"19","author":"F Bonsack","year":"2018","unstructured":"Bonsack F, Sukumari-Ramesh S (2018) TSPO: An Evolutionarily Conserved Protein with Elusive Functions. Int J Mol Sci 19(6):1694. https:\/\/doi.org\/10.3390\/ijms19061694","journal-title":"Int J Mol Sci"},{"key":"2737_CR76","doi-asserted-by":"publisher","unstructured":"Papadopoulos V, Fan J and Zirkin B (2018) Translocator protein (18 kDa): an update on its function in steroidogenesis. J Neuroendocrinol 30(2):https:\/\/doi.org\/10.1111\/jne.12500.","DOI":"10.1111\/jne.12500"},{"issue":"4","key":"2737_CR77","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/1566524011207040387","volume":"12","author":"AM Scarf","year":"2012","unstructured":"Scarf AM, Auman KM, Kassiou M (2012) Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa)? Curr Mol Med 12(4):387\u2013397. https:\/\/doi.org\/10.2174\/1566524011207040387","journal-title":"Curr Mol Med"},{"issue":"12","key":"2737_CR78","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, Groyer G, Adams D, Schumacher M (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9(12):971\u2013988. https:\/\/doi.org\/10.1038\/nrd3295","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2737_CR79","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Y Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251(3):261\u2013268. https:\/\/doi.org\/10.1007\/s00415-004-0348-9","journal-title":"J Neurol"},{"issue":"8","key":"2737_CR80","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1177\/1352458517711568","volume":"24","author":"IY Choi","year":"2018","unstructured":"Choi IY, Lee P, Adany P, Hughes AJ, Belliston S, Denney DR, Lynch SG (2018) In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis. Mult Scler 24(8):1029\u20131038. https:\/\/doi.org\/10.1177\/1352458517711568","journal-title":"Mult Scler"},{"issue":"5","key":"2737_CR81","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.tips.2016.02.008","volume":"37","author":"TR Guilarte","year":"2016","unstructured":"Guilarte TR, Loth MK, Guariglia SR (2016) TSPO Finds NOX2 in Microglia for Redox Homeostasis. Trends Pharmacol Sci 37(5):334\u2013343. https:\/\/doi.org\/10.1016\/j.tips.2016.02.008","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"2737_CR82","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12640-017-9733-x","volume":"32","author":"E Baez","year":"2017","unstructured":"Baez E, Guio-Vega GP, Echeverria V, Sandoval-Rueda DA, Barreto GE (2017) 4\u2019-Chlorodiazepam Protects Mitochondria in T98G Astrocyte Cell Line from Glucose Deprivation. Neurotox Res 32(2):163\u2013171. https:\/\/doi.org\/10.1007\/s12640-017-9733-x","journal-title":"Neurotox Res"},{"issue":"4","key":"2737_CR83","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.3233\/JAD-190127","volume":"72","author":"I Lejri","year":"2019","unstructured":"Lejri I, Grimm A, Halle F, Abarghaz M, Klein C, Maitre M, Schmitt M, Bourguignon JJ, Mensah-Nyagan AG, Bihel F, Eckert A (2019) TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis. J Alzheimers Dis 72(4):1045\u20131058. https:\/\/doi.org\/10.3233\/JAD-190127","journal-title":"J Alzheimers Dis"},{"key":"2737_CR84","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jneuroim.2018.02.008","volume":"318","author":"E Allender","year":"2018","unstructured":"Allender E, Deol H, Schram S, Maheras KJ, Gow A, Simpson EH, Song F (2018) Neuregulin1 modulation of experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 318:56\u201364. https:\/\/doi.org\/10.1016\/j.jneuroim.2018.02.008","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"2737_CR85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jneuroim.2004.01.018","volume":"150","author":"TL Papenfuss","year":"2004","unstructured":"Papenfuss TL, Rogers CJ, Gienapp I, Yurrita M, McClain M, Damico N, Valo J, Song F, Whitacre CC (2004) Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains. J Neuroimmunol 150(1\u20132):59\u201369. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.01.018","journal-title":"J Neuroimmunol"},{"key":"2737_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneumeth.2020.108999","volume":"351","author":"R Aharoni","year":"2021","unstructured":"Aharoni R, Globerman R, Eilam R, Brenner O, Arnon R (2021) Titration of myelin oligodendrocyte glycoprotein (MOG) - Induced experimental autoimmune encephalomyelitis (EAE) model. J Neurosci Methods 351:108999. https:\/\/doi.org\/10.1016\/j.jneumeth.2020.108999","journal-title":"J Neurosci Methods"},{"key":"2737_CR87","doi-asserted-by":"publisher","unstructured":"Fjaer S, Bo L, Myhr KM, Torkildsen O and Wergeland S (2015) Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model. Neurochem Int 83\u201384(28\u201340. https:\/\/doi.org\/10.1016\/j.neuint.2015.02.006.","DOI":"10.1016\/j.neuint.2015.02.006"},{"issue":"15","key":"2737_CR88","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1177\/1535370217724791","volume":"242","author":"MD Ludwig","year":"2017","unstructured":"Ludwig MD, Zagon IS, McLaughlin PJ (2017) Featured Article: Serum [Met(5)]-enkephalin levels are reduced in multiple sclerosis and restored by low-dose naltrexone. Exp Biol Med (Maywood) 242(15):1524\u20131533. https:\/\/doi.org\/10.1177\/1535370217724791","journal-title":"Exp Biol Med (Maywood)"},{"issue":"1","key":"2737_CR89","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12974-020-01936-9","volume":"17","author":"NB Teixeira","year":"2020","unstructured":"Teixeira NB, Picolo G, Giardini AC, Boumezbeur F, Pottier G, Kuhnast B, Servent D, Benoit E (2020) Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis. J Neuroinflammation 17(1):266. https:\/\/doi.org\/10.1186\/s12974-020-01936-9","journal-title":"J Neuroinflammation"},{"key":"2737_CR90","doi-asserted-by":"publisher","unstructured":"Yousuf MS, Noh MC, Friedman TN, Zubkow K, Johnson JC, Tenorio G, Kurata HT, Smith PA and Kerr BJ (2019) Sensory Neurons of the Dorsal Root Ganglia Become Hyperexcitable in a T-Cell-Mediated MOG-EAE Model of Multiple Sclerosis. eNeuro 6(2):https:\/\/doi.org\/10.1523\/ENEURO.0024-19.2019.","DOI":"10.1523\/ENEURO.0024-19.2019"},{"issue":"6","key":"2737_CR91","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR (2006) The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126(6):1121\u20131133. https:\/\/doi.org\/10.1016\/j.cell.2006.07.035","journal-title":"Cell"},{"issue":"1","key":"2737_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1056\/NEJMoa020696","volume":"348","author":"DH Miller","year":"2003","unstructured":"Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer-Hulme AJ, Dalton CM, Miszkiel KA, O\u2019Connor PW (2003) A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med 348(1):15\u201323. https:\/\/doi.org\/10.1056\/NEJMoa020696","journal-title":"N Engl J Med"},{"issue":"7","key":"2737_CR93","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1073\/pnas.96.7.3842","volume":"96","author":"D Teitelbaum","year":"1999","unstructured":"Teitelbaum D, Arnon R, Sela M (1999) Immunomodulation of experimental autoimmune encephalomyelitis by oral administration of copolymer 1. Proc Natl Acad Sci U S A 96(7):3842\u20133847. https:\/\/doi.org\/10.1073\/pnas.96.7.3842","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7191","key":"2737_CR94","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature06881","volume":"453","author":"M Veldhoen","year":"2008","unstructured":"Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453(7191):106\u2013109. https:\/\/doi.org\/10.1038\/nature06881","journal-title":"Nature"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-022-02737-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-022-02737-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,22]],"date-time":"2023-01-22T11:56:07Z","timestamp":1674388567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-022-02737-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2737"],"URL":"https:\/\/doi.org\/10.1007\/s12035-022-02737-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"30 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"\"Christine Patte-Mensah and Ayiko\u00e9-Guy Mensah-Nyagan are co-seniors.\" was added in print proofs.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed: Ministry of Higher Education and Research, France and CREMEAS ethical committee authorization number 9374\u2013201605111128746-v2. This study does not contain any experiments with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"<sup>1<\/sup> Biopathologie de la My\u00e9line, Neuroprotection et Strat\u00e9gies Th\u00e9rapeutiques, INSERM U1119, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle de Strasbourg (FMTS), Universit\u00e9 de Strasbourg, B\u00e2timent CRBS de la Facult\u00e9 de M\u00e9decine, 1 rue Eug\u00e8ne Boeckel, 67 000 Strasbourg, France.<sup>2<\/sup> Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author details"}}]}}